Market Tracker

04/29 5:16pm ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.26
Delayed Data
As of Apr 29
 -0.06 / -1.81%
Today’s Change
1.63
Today|||52-Week Range
16.83
-68.41%
Year-to-Date

Today’s Trading

Previous close3.32
Today’s open3.31
Day’s range3.14 - 3.40
Volume938,725
Average volume (3 months)1,377,906
Market cap$244.6M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+13.24%
Earnings growth (this year)-60.83%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)+254.62%
P/E ratioNM
Price/Sales15.59
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.23-2.72%
OVASOvaScience Inc-0.51-5.74%
KMPHKemPharm Inc0.000.00%
AXSMAxsome Therapeutics ...-0.96-7.74%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$48.3M
Annual profit (last year)-$43.0M
Net profit margin-89.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts